ImmunoCellular Therapeutics Story
| IMUCDelisted Stock | USD 0.47 0.00 0.00% |
About 56% of ImmunoCellular Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading ImmunoCellular Therapeutics pink sheet suggests that many investors are alarmed at this time. ImmunoCellular Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in ImmunoCellular Therapeutics. The current market sentiment, together with ImmunoCellular Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use ImmunoCellular Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ImmunoCellular Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ImmunoCellular daily returns and investor perception about the current price of ImmunoCellular Therapeutics as well as its diversification or hedging effects on your existing portfolios.
ImmunoCellular |
Requested story not found. it has been either deleted or moved. View all stories for ImmunoCellular Therapeutics.
ImmunoCellular Therapeutics Latest Timeline
ImmunoCellular Therapeutics is listed for 0.47. About 95.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. ImmunoCellular Therapeutics recorded earning per share (EPS) of 28.91. The entity last dividend was issued on the 16th of September 2020. The firm had 1:10 split on the 16th of September 2020.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in ImmunoCellular Pink Sheet
If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |